These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15690202)

  • 1. Significance of vascular endothelial growth factor and epidermal growth factor in development of papillary thyroid cancer.
    Konturek A; Barczyński M; Cichoń S; Pituch-Noworolska A; Jonkisz J; Cichoń W
    Langenbecks Arch Surg; 2005 Jun; 390(3):216-21. PubMed ID: 15690202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
    Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma.
    de Araujo-Filho VJ; Alves VA; de Castro IV; Lourenço SV; Cernea CR; Brandão LG; Ferraz AR
    Thyroid; 2009 Nov; 19(11):1233-7. PubMed ID: 19888861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer.
    Lennard CM; Patel A; Wilson J; Reinhardt B; Tuman C; Fenton C; Blair E; Francis GL; Tuttle RM
    Surgery; 2001 May; 129(5):552-8. PubMed ID: 11331447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Leung P; Luk JM
    Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between preoperative serum TSH levels and expression of VEGF in papillary thyroid carcinoma.
    Li J; Teng L; Jiang H
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):149-52. PubMed ID: 23718885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults.
    Fenton C; Patel A; Dinauer C; Robie DK; Tuttle RM; Francis GL
    Thyroid; 2000 Apr; 10(4):349-57. PubMed ID: 10807064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
    Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
    Tuttle RM; Fleisher M; Francis GL; Robbins RJ
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
    Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
    Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
    Hoelting T; Siperstein AE; Clark OH; Duh QY
    J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of VEGF-C, VEGF-D and VEGFR-3 levels combined with serum TSH in diagnosis of papillary thyroid carcinoma].
    Huang J; Li Y; Xue G; Zhang W; Li S; Zhang J; Wu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1814-7, 1821. PubMed ID: 25537909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Vascular Endothelial Growth Factor and Its Receptors in Thyroid Nodular Hyperplasia and Papillary Thyroid Carcinoma: A Tertiary Health Care Centre Based Study.
    Mohamad Pakarul Razy NH; Wan Abdul Rahman WF; Win TT
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):277-282. PubMed ID: 30678450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OPG, OPN, EGF and VEGF Levels at Individual Breslow Score Stages in Malignant Melanoma.
    Treskova I; Topolcan O; Windrichova J; Simanek V; Slouka D; Treska V; Kucera R
    Anticancer Res; 2018 Aug; 38(8):4907-4911. PubMed ID: 30061268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-C and COX-2 expression in papillary thyroid cancer.
    Siironen P; Ristimäki A; Narko K; Nordling S; Louhimo J; Andersson S; Haapiainen R; Haglund C
    Endocr Relat Cancer; 2006 Jun; 13(2):465-73. PubMed ID: 16728574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.
    Jo YS; Li S; Song JH; Kwon KH; Lee JC; Rha SY; Lee HJ; Sul JY; Kweon GR; Ro HK; Kim JM; Shong M
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3667-70. PubMed ID: 16772349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture.
    Toda S; Nishimura T; Yamada S; Koike N; Yonemitsu N; Watanabe K; Matsumura S; Gärtner R; Sugihara H
    J Pathol; 1999 Aug; 188(4):415-22. PubMed ID: 10440753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma.
    Lai CW; Chen KY; Hung CS; Kuo SW; Chang YJ; Lin MT; Chang KC; Wu MH
    Growth Factors; 2011 Apr; 29(2-3):57-62. PubMed ID: 21319951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.